<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> patients are prone to <z:hpo ids='HP_0001724'>aortic dilatation</z:hpo>, dissection, and rupture </plain></SENT>
<SENT sid="1" pm="."><plain>Success of aortic root replacement has generated a cohort of patients surviving longer and presenting with distal <z:hpo ids='HP_0002647'>aortic dissection</z:hpo> and enlargement </plain></SENT>
<SENT sid="2" pm="."><plain>Thoracic endovascular stent-graft repair (TEVR) is being increasingly utilized to exclude <z:hpo ids='HP_0002617'>aneurysms</z:hpo> resulting from <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002647'>aortic dissection</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>This report explores the role of TEVR in Marfan patients with this pathology </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Review of a prospectively maintained database identified seven patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> offered endovascular repair of aneurysmal <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002647'>aortic dissection</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had previous aortic root repair </plain></SENT>
<SENT sid="6" pm="."><plain>Talent or Valiant (Medtronic Vascular, Santa Rosa, Calif) aortic stent-grafts were used to occlude the dissection entry tear and cover the thoracic aorta </plain></SENT>
<SENT sid="7" pm="."><plain>Electronic data, case notes, and radiological surveillance were analyzed </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: Seven consecutive patients (six male; mean age, 45.9 +/- 10 years, range, 29 to 63) underwent successful thoracic stent-graft deployment </plain></SENT>
<SENT sid="9" pm="."><plain>Mean aortic aneurysmal diameter was 63.4mm (+/-11.2) with six of seven dissections extending to the aortic bifurcation </plain></SENT>
<SENT sid="10" pm="."><plain>No perioperative neurological events occurred </plain></SENT>
<SENT sid="11" pm="."><plain>Thirty-day mortality was 1/7 (14%) due to congestive <z:hpo ids='HP_0001635'>cardiac failure</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>At median 16 month follow-up, two of six cases (33%) required intervention for endoleak </plain></SENT>
<SENT sid="13" pm="."><plain>Aortic false lumen <z:mp ids='MP_0005048'>thrombosis</z:mp> (FLT) occurred in 5/6 (83%) cases and partial FLT occurred in 1/6 (17%) </plain></SENT>
<SENT sid="14" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> thoracic aortas continued to dilate during follow-up </plain></SENT>
<SENT sid="15" pm="."><plain>Crude median aortic growth rate was 7.2 mm/year (range, 3.5 to 19 mm) </plain></SENT>
<SENT sid="16" pm="."><plain>CONCLUSION: TEVR in <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002647'>aortic dissection</z:hpo> is technically feasible </plain></SENT>
<SENT sid="17" pm="."><plain>However, post intervention surveillance confirms that the aorta continues to dilate despite graft deployment and false lumen <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="18" pm="."><plain>Endovascular repair may offer a viable option in patients who have contraindications to open surgery, but longer follow up of more patients is required to define the place of this therapy </plain></SENT>
</text></document>